9Achromobacter xylosoxidans is an emerging pathogen increasingly being isolated from respiratory samples of cystic fibrosis (CF) patients. Its role and clinical significance in lung pathogenesis have not yet been clarified. The aim of the present study was to genetically characterize A. xylosoxidans strains isolated from CF patients by use of randomly amplified polymorphic DNA (RAPD) profiles and to look for a possible correlation between RAPD profiles and the patients' clinical features, such as their spirometry values, the presence of concomitant chronic bacterial flora at the time of isolation, and the persistent or intermittent presence of A. xylosoxidans strains. A set of 106 strains of A. xylosoxidans were typed by RAPD analysis, and ...
The genus Achromobacter currently is comprised of seven species, including Achromobacter xylosoxidan...
International audienceBacteria of the genus Achromobacter are environmental germs, with an unknown r...
Achromobacter spp. are emerging pathogens in the lungs of patients with cystic fibrosis. We report t...
Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, wh...
Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, wh...
11Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, ...
The aims of this study were to evaluate the frequency of Achromobacter xylosoxidans infection in a c...
Pulmonary infections by Gram-negative bacteria such as Achromobacter xylosoxidans are recovered freq...
The opportunistic human pathogen Achromobacter (Alcaligenes) xylosoxidans has been recovered with in...
Bacterial pathogens evolve during chronic colonization of the human host by selection for pathoadapt...
Achromobacter xylosoxidans is an environmental opportunistic pathogen, which infects an increasing n...
Achromobacter xylosoxidans is an environmental opportunistic pathogen, which infects an increasing n...
AbstractBackgroundAchromobacter xylosoxidans is increasingly cultured in sputum from cystic fibrosis...
AbstractBackgroundWe recently described a multilocus sequence typing scheme for Achromobacter that i...
During a study examining transmission of Pseudomonas aeruginosa among 76 cystic fibrosis patients in...
The genus Achromobacter currently is comprised of seven species, including Achromobacter xylosoxidan...
International audienceBacteria of the genus Achromobacter are environmental germs, with an unknown r...
Achromobacter spp. are emerging pathogens in the lungs of patients with cystic fibrosis. We report t...
Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, wh...
Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, wh...
11Cystic fibrosis (CF) patients have chronic airway infection and frequent exposure to antibiotics, ...
The aims of this study were to evaluate the frequency of Achromobacter xylosoxidans infection in a c...
Pulmonary infections by Gram-negative bacteria such as Achromobacter xylosoxidans are recovered freq...
The opportunistic human pathogen Achromobacter (Alcaligenes) xylosoxidans has been recovered with in...
Bacterial pathogens evolve during chronic colonization of the human host by selection for pathoadapt...
Achromobacter xylosoxidans is an environmental opportunistic pathogen, which infects an increasing n...
Achromobacter xylosoxidans is an environmental opportunistic pathogen, which infects an increasing n...
AbstractBackgroundAchromobacter xylosoxidans is increasingly cultured in sputum from cystic fibrosis...
AbstractBackgroundWe recently described a multilocus sequence typing scheme for Achromobacter that i...
During a study examining transmission of Pseudomonas aeruginosa among 76 cystic fibrosis patients in...
The genus Achromobacter currently is comprised of seven species, including Achromobacter xylosoxidan...
International audienceBacteria of the genus Achromobacter are environmental germs, with an unknown r...
Achromobacter spp. are emerging pathogens in the lungs of patients with cystic fibrosis. We report t...